Arkolith/Insider Trading/CRXT/Form 4

Dudley Robert E.

Chief Executive Officer, DirectorClarus Therapeutics Holdings, Inc. (CRXT) · full profile →Form 4 · filed Dec 14, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2021Grant(A)135K—$0140K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 12, 2021Grant(A)338K—$0338K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-21-048206) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML